{"protocolSection": {"identificationModule": {"nctId": "NCT00965991", "orgStudyIdInfo": {"id": "HRRC#03-277"}, "organization": {"fullName": "University of New Mexico", "class": "OTHER"}, "briefTitle": "Metformin Compared to Glyburide in Gestational Diabetes", "officialTitle": "A Randomized Prospective Trial of Metformin Compared to Glyburide in Gestational Diabetes"}, "statusModule": {"statusVerifiedDate": "2023-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2003-07", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2008-05", "type": "ACTUAL"}, "completionDateStruct": {"date": "2023-08", "type": "ACTUAL"}, "studyFirstSubmitDate": "2009-08-24", "studyFirstSubmitQcDate": "2009-08-24", "studyFirstPostDateStruct": {"date": "2009-08-26", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2023-08-23", "resultsFirstSubmitQcDate": "2023-12-01", "resultsFirstPostDateStruct": {"date": "2023-12-21", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-12-01", "lastUpdatePostDateStruct": {"date": "2023-12-21", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "University of New Mexico", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Our hypothesis is that metformin and glyburide will have equal efficacy in controlling blood glucose in gestational diabetics with no increase in adverse maternal, fetal or neonatal outcomes.", "detailedDescription": "Pregnant women are screened with a one hour 50g glucose challenge. Women with values of 130 mg/dl or greater are then given a 100g glucose tolerance test. Two abnormal values are diagnostic of gestational diabetes. all women are initially counseled on diet and exercise. Women who fail to maintain a fasting of \\<105mg/dl and 2 hr postprandial \\< 120 mg/dl are offered participation in the study. Women were randomized to either metformin or glyburide via a computer generated randomization. Women who fail to meet glycemic goals after receiving the maximum dose of study medication were considered treatment failures and insulin therapy was initiated."}, "conditionsModule": {"conditions": ["Gestational Diabetes"], "keywords": ["Gestational diabetes", "Metformin", "Glyburide", "oral agents"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 149, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Metformin", "type": "ACTIVE_COMPARATOR", "interventionNames": ["Drug: metformin"]}, {"label": "Glyburide", "type": "ACTIVE_COMPARATOR", "interventionNames": ["Drug: Glyburide"]}], "interventions": [{"type": "DRUG", "name": "metformin", "description": "patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose", "armGroupLabels": ["Metformin"], "otherNames": ["Glucophage"]}, {"type": "DRUG", "name": "Glyburide", "description": "Initial dose of 2.5mg PO BID increased as necessary to a maximum dose of 20 mg (10mg BID) QD to control blood glucose", "armGroupLabels": ["Glyburide"], "otherNames": ["sulfonylurea"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants Assessed for Glucose Control", "description": "The importance of exercise in the management of blood glucose was emphasized, and 30 minutes of walking per day was recommended. Patients received instruction from a nurse educator or a certified diabetes educator regarding diet and the use of the glucometer. Number of participants with a glucose level \\<100 mg/dL.", "timeFrame": "fasting and 2 hour postprandial blood glucose"}], "secondaryOutcomes": [{"measure": "Neonatal and Obstetric Complications.", "timeFrame": "postpartum"}, {"measure": "Failure Rate of the Drug to Control Blood Glucose", "timeFrame": "at weekly visit"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Gestational diabetes not controlled with diet and exercise\n\nExclusion Criteria:\n\n* history of alcohol misuse\n* history of drug misuse\n* Chronic hypertension requiring medication\n* Renal failure\n* Hepatic disease or dysfunction\n* Known fetal anomaly\n* Inability to give consent\n* known allergy to metformin or glyburide", "healthyVolunteers": true, "sex": "FEMALE", "minimumAge": "13 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Lisa E Moore, MD", "affiliation": "University of New Mexico", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "University of New Mexico Diabetes in Pregnancy Clinic", "city": "Albuquerque", "state": "New Mexico", "zip": "87131", "country": "United States", "geoPoint": {"lat": 35.08449, "lon": -106.65114}}]}, "referencesModule": {"references": [{"pmid": "20027034", "type": "RESULT", "citation": "Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010 Jan;115(1):55-59. doi: 10.1097/AOG.0b013e3181c52132."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "ARM 1: Metformin", "description": "Patients received metformin initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose"}, {"id": "FG001", "title": "ARM 2: Glyburide", "description": "Patients received glyburide initial dose of 2.5mg PO BID. Increased as necessary to a maximum dose of 20 mg/d to control blood glucose"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "75"}, {"groupId": "FG001", "numSubjects": "74"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "75"}, {"groupId": "FG001", "numSubjects": "74"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "ARM 1: Metformin", "description": "Metformin: Patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose"}, {"id": "BG001", "title": "ARM 2: Glyburide", "description": "Glyburide: Patients received glyburide initial dose of 2.5mg PO BID. Increased as necessary to a maximum dose of 20 mg/d to control blood glucose"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "calculatePct": false, "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}], "categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "31", "spread": "7.1"}, {"groupId": "BG001", "value": "30", "spread": "7.8"}, {"groupId": "BG002", "value": "30", "spread": "7.4"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "149"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants Assessed for Glucose Control", "description": "The importance of exercise in the management of blood glucose was emphasized, and 30 minutes of walking per day was recommended. Patients received instruction from a nurse educator or a certified diabetes educator regarding diet and the use of the glucometer. Number of participants with a glucose level \\<100 mg/dL.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "fasting and 2 hour postprandial blood glucose", "groups": [{"id": "OG000", "title": "Metformin", "description": "metformin: patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose"}, {"id": "OG001", "title": "Glyburide", "description": "Glyburide: Initial dose of 2.5mg PO BID increased as necessary to a maximum dose of 20 mg (10mg BID) QD to control blood glucose"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "74"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "50"}, {"groupId": "OG001", "value": "50"}]}]}]}, {"type": "SECONDARY", "title": "Neonatal and Obstetric Complications.", "reportingStatus": "NOT_POSTED", "timeFrame": "postpartum", "denomUnitsSelected": "Participants"}, {"type": "SECONDARY", "title": "Failure Rate of the Drug to Control Blood Glucose", "reportingStatus": "NOT_POSTED", "timeFrame": "at weekly visit", "denomUnitsSelected": "Participants"}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "4 years", "eventGroups": [{"id": "EG000", "title": "ARM 1: Metformin", "description": "Metformin: Patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose", "deathsNumAffected": 0, "deathsNumAtRisk": 75, "seriousNumAffected": 0, "seriousNumAtRisk": 75, "otherNumAffected": 0, "otherNumAtRisk": 75}, {"id": "EG001", "title": "ARM 2: Glyburide", "description": "Glyburide: Patients received glyburide initial dose of 2.5mg PO BID. Increased as necessary to a maximum dose of 20 mg/d to control blood glucose", "deathsNumAffected": 0, "deathsNumAtRisk": 74, "seriousNumAffected": 0, "seriousNumAtRisk": 74, "otherNumAffected": 0, "otherNumAtRisk": 74}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Lisa Moore", "organization": "University of New Mexico", "email": "hkhawaja@salud.unm.edu", "phone": "5052727028"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000016640", "term": "Diabetes, Gestational"}, {"id": "D000003920", "term": "Diabetes Mellitus"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}, {"id": "D000011248", "term": "Pregnancy Complications"}, {"id": "D000005261", "term": "Female Urogenital Diseases and Pregnancy Complications"}, {"id": "D000091642", "term": "Urogenital Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes", "relevance": "HIGH"}, {"id": "M19012", "name": "Diabetes, Gestational", "asFound": "Gestational Diabetes", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}, {"id": "M14127", "name": "Pregnancy Complications", "relevance": "LOW"}, {"id": "M2875", "name": "Urogenital Diseases", "relevance": "LOW"}, {"id": "M27093", "name": "Female Urogenital Diseases", "relevance": "LOW"}, {"id": "M8399", "name": "Female Urogenital Diseases and Pregnancy Complications", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BXS", "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}, {"id": "D000005905", "term": "Glyburide"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M9017", "name": "Glyburide", "asFound": "Lumefantrine", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}